Holen Sie sich die Stockscreener-App
269.66
6.24%
15.84
Handel nachbörslich:
269.66
Schlusskurs vom Vortag:
$253.82
Offen:
$252.39
24-Stunden-Volumen:
1.18M
Relative Volume:
0.80
Marktkapitalisierung:
$38.62B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-164.31
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+1.88%
1M Leistung:
-0.97%
6M Leistung:
+16.67%
1J Leistung:
+91.30%
1-Tages-Spanne:
$252.39
$271.25
1-Wochen-Bereich:
$248.03
$271.25
52-Wochen-Spanne:
$131.81
$288.04
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
269.66 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
576.77 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.17 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
558.80 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
IQV
Iqvia Holdings Inc
|
237.79 | 35.59B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
138.71 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Long term debt to total assets ratio of Natera, Inc. – HAM:45E - TradingView
Natera, Inc. Revenue Breakdown – HAM:45E - TradingView
Form 144 NATERA For: 27 July By Investing.com - Investing.com Canada
NTRA (NTRA) affiliate plans sale of 68,976 shares after RSU grant - Stock Titan
Company insider Jonathan Sheena (NTRA) files notice to sell more common stock - Stock Titan
Planned sale of 873 NTRA shares and prior insider stock transactions - Stock Titan
Planned sale of 998 NTRA shares follows earlier 2026 insider trades - Stock Titan
Planned insider stock sale disclosed by NTRA filer John Fesko - Stock Titan
E*TRADE Corporation (NTRA) insider Steven Chapman plans $566K stock sale - Stock Titan
NTRA company insider Michael Brophy plans $202K stock sale in 2026 - Stock Titan
NTRA|Natera Inc|Price:258.215|Chg%:-3.775 - TradingKey
Natera Inc (NTRA) Balance Sheet - TradingKey
Natera Inc (NTRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Natera Inc (NTRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Natera, Inc. (NTRA) stock price, news, quote and history - Yahoo Finance UK
What's Driving Natera's Recent Stock Action, and Why Are Insiders Selling - Kavout | AI
Natera, Inc. (NTRA) options chain - Yahoo Finance Australia
Natera (NTRA) Stock Looks Stretched On Sales Yet Strong On Returns - simplywall.st
Natera, Inc. (NTRA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Natera Inc (NTRA) Institutional Confidence - TradingKey
Natera Inc|Price:261.990|Chg%:-2.700 - TradingKey
NTRA|Natera Inc|Price:261.990|Chg%:-2.700 - TradingKey
What's Driving Natera's Recent Stock Action and Insider Selling - Kavout | AI
Natera Inc (NTRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Natera Inc (NTRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
3 Reasons We’re Fans of Natera (NTRA) - Yahoo Finance
NTRA5169220 Bond Profile — Key Metrics - TradingView
Natera (NTRA) Gets a Buy from BTIG - The Globe and Mail
NTRA|Natera Inc|Price:264.550|Chg%:+0.330 - TradingKey
Natera Inc (NTRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Natera Inc. (NTRA) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
J.P. Morgan Remains a Buy on Natera (NTRA) - The Globe and Mail
Natera (NTRA) Reveals Promising Advances in Merkel Cell Carcinom - GuruFocus
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring - Sahm
Natera’s Signatera test outperforms standard MCC monitoring tool By Investing.com - Investing.com South Africa
Natera’s Signatera test outperforms standard MCC monitoring tool - Investing.com
Natera Inc. (NTRA) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
What's Driving Natera's Recent Stock Action - Kavout | AI
Form 4 Natera Inc For: 21 July By Investing.com - Investing.com South Africa
Natera co-founder Sheena sells $410,825 of company stock - Investing.com UK
Natera co-founder Sheena sells $410,825 of company stock By Investing.com - Investing.com South Africa
Natera director Rowan Chapman sells $37,100 in shares - Investing.com UK
Natera Inc. (NTRA) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Natera director Rowan Chapman sells $37,100 in shares By Investing.com - Investing.com South Africa
Natera stock trades steady as genetic testing growth supports recent earnings - Ad-hoc-news.de
(NTRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Natera Inc. (NTRA) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Natera Inc. (NTRA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Natera Inc. (NTRA) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Natera (NTRA) On Prospera Coverage Expansion And Revenue Strength Looks Fully Valued - simplywall.st
Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91 - Bitget
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
Jul 28 '26 |
Sale |
254.07 |
191 |
48,527 |
245,723 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Jul 27 '26 |
Sale |
260.49 |
1,718 |
447,523 |
2,276,125 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Jul 28 '26 |
Sale |
254.07 |
1,003 |
254,833 |
170,407 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Jul 27 '26 |
Sale |
260.49 |
884 |
230,274 |
171,410 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Jul 28 '26 |
Sale |
254.07 |
1,204 |
305,901 |
132,429 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Jul 27 '26 |
Sale |
260.49 |
1,010 |
263,096 |
133,633 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Jul 28 '26 |
Sale |
254.07 |
931 |
236,540 |
184,069 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Jul 27 '26 |
Sale |
260.49 |
782 |
203,704 |
185,000 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Jul 28 '26 |
Sale |
254.07 |
3,580 |
909,572 |
102,973 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Jul 27 '26 |
Sale |
260.49 |
2,190 |
570,475 |
106,553 |
1.13%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):